Published in J Immunol on November 15, 1989
Virulent Brucella abortus prevents lysosome fusion and is distributed within autophagosome-like compartments. Infect Immun (1998) 2.55
Effects of cytokines on intracellular growth of Brucella abortus. Infect Immun (1993) 2.33
Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev (2003) 2.03
Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis. Infect Immun (1994) 1.93
Deletion of purE attenuates Brucella melitensis infection in mice. Infect Immun (1996) 1.88
Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology (2001) 1.74
Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51. Infect Immun (1995) 1.71
The Brucella abortus Cu,Zn superoxide dismutase is required for optimal resistance to oxidative killing by murine macrophages and wild-type virulence in experimentally infected mice. Infect Immun (2005) 1.55
Cytokine production in the murine response to brucella infection or immunization with antigenic extracts. Immunology (1993) 1.54
Immune and pathologic responses in mice infected with Brucella abortus 19, RB51, or 2308. Infect Immun (1994) 1.54
Expression and bactericidal activity of nitric oxide synthase in Brucella suis-infected murine macrophages. Infect Immun (1998) 1.48
Identification of an immunoreactive Brucella abortus HtrA stress response protein homolog. Infect Immun (1994) 1.47
Cytokine response of T-cell subsets from Brucella abortus-infected mice to soluble Brucella proteins. Infect Immun (1993) 1.44
The HtrA stress response protease contributes to resistance of Brucella abortus to killing by murine phagocytes. Infect Immun (1996) 1.36
Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines. Infect Immun (1994) 1.35
Differential activation of Brucella-reactive CD4+ T cells by Brucella infection or immunization with antigenic extracts. Infect Immun (1995) 1.33
Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51. Infect Immun (2001) 1.33
Cloning and sequencing of yajC and secD homologs of Brucella abortus and demonstration of immune responses to YajC in mice vaccinated with B. abortus RB51. Infect Immun (1998) 1.29
Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis. Infect Immun (1996) 1.24
Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19. Immunology (1994) 1.23
Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation. Infect Immun (2000) 1.22
Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Infect Immun (2001) 1.19
Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses. Infect Immun (2000) 1.18
Brucellosis: review on the recent trends in pathogenicity and laboratory diagnosis. J Lab Physicians (2010) 1.17
A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response. Infect Immun (2005) 1.16
What have we learned from brucellosis in the mouse model? Vet Res (2012) 1.13
Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection. Infect Immun (2005) 1.13
A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection. Proc Natl Acad Sci U S A (2006) 1.13
Impaired control of Brucella melitensis infection in Rag1-deficient mice. Infect Immun (2000) 1.11
Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK). Infect Immun (1999) 1.09
The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice. Infect Immun (2010) 1.08
Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions. Am J Pathol (2015) 1.07
Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used. Infect Immun (2003) 1.06
Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kilodalton outer membrane protein of Brucella abortus. Clin Diagn Lab Immunol (2000) 1.06
Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp. Infect Immun (2001) 1.05
Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type. Infect Immun (2002) 1.05
Laboratory animal models for brucellosis research. J Biomed Biotechnol (2011) 1.05
Protection against infection in mice vaccinated with a Brucella abortus mutant. Infect Immun (1997) 1.03
Brucella abortus RB51 induces protection in mice orally infected with the virulent strain B. abortus 2308. Infect Immun (2003) 1.03
Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice. Infect Immun (2012) 1.02
Lack of a role for natural killer cells in early control of Brucella abortus 2308 infections in mice. Infect Immun (1995) 1.02
Identification and characterization of a Brucella abortus ATP-binding cassette transporter homolog to Rhizobium meliloti ExsA and its role in virulence and protection in mice. Infect Immun (2002) 1.01
Host susceptibility to Brucella abortus infection is more pronounced in IFN-γ knockout than IL-12/β2-microglobulin double-deficient mice. Clin Dev Immunol (2011) 0.99
Lymphocyte proliferation in response to Brucella abortus 2308 or RB51 antigens in mice infected with strain 2308, RB51, or 19. Infect Immun (1994) 0.99
Analyses of Brucella pathogenesis, host immunity, and vaccine targets using systems biology and bioinformatics. Front Cell Infect Microbiol (2012) 0.97
Bacterial persistence and immunity in goats vaccinated with a purE deletion mutant or the parental 16M strain of Brucella melitensis. Infect Immun (1996) 0.96
Comparison of spleen cell proliferation in response to Brucella abortus 2308 lipopolysaccharide or proteins in mice vaccinated with strain 19 or RB51. Infect Immun (1995) 0.95
Recombinant L7/L12 ribosomal protein and gamma-irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4+ T cells. Immunology (1994) 0.91
Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen. Infect Immun (2002) 0.89
Activation of human Vgamma9Vdelta2 T cells by a Brucella suis non-peptidic fraction impairs bacterial intracellular multiplication in monocytic infected cells. Immunology (2000) 0.89
Immune responses of elk to initial and booster vaccinations with Brucella abortus strain RB51 or 19. Clin Vaccine Immunol (2006) 0.88
Nondividing but metabolically active gamma-irradiated Brucella melitensis is protective against virulent B. melitensis challenge in mice. Infect Immun (2009) 0.88
Carboxyl-terminal protease regulates Brucella suis morphology in culture and persistence in macrophages and mice. J Bacteriol (2005) 0.87
Immunological response to the Brucella abortus GroEL homolog. Infect Immun (1996) 0.87
Effect of recombinant human macrophage colony-stimulating factor 1 on immunopathology of experimental brucellosis in mice. Infect Immun (1992) 0.86
Immunization of mice with gamma-irradiated Brucella neotomae and its recombinant strains induces protection against virulent B. abortus, B. melitensis, and B. suis challenge. Vaccine (2010) 0.85
Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella. J Immune Based Ther Vaccines (2009) 0.84
Identification and characterization of a 14-kilodalton Brucella abortus protein reactive with antibodies from naturally and experimentally infected hosts and T lymphocytes from experimentally infected BALB/c mice. Infect Immun (1998) 0.83
Immunogenic and invasive properties of Brucella melitensis 16M outer membrane protein vaccine candidates identified via a reverse vaccinology approach. PLoS One (2013) 0.83
Alteration of protective and serologic responses in BALB/c mice vaccinated with chemically modified versus nonmodified proteins of Brucella abortus 19. Infect Immun (1994) 0.83
Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis. Front Cell Infect Microbiol (2013) 0.82
Brucella melitensis invades murine erythrocytes during infection. Infect Immun (2014) 0.82
Human brucellosis is characterized by an intense Th1 profile associated with a defective monocyte function. Infect Immun (2010) 0.80
Cell response to a salt-extractable and sonicated Brucella melitensis 16M antigen in human brucellosis. Clin Diagn Lab Immunol (1995) 0.79
Variation of Brucella abortus 2308 infection in BALB/c mice induced by prior vaccination with salt-extractable periplasmic proteins from Brucella abortus 19. Infect Immun (1996) 0.79
Use of S-[2,3-bispalmitoyiloxy-(2R)-propyl]-R-cysteinyl-amido-monomethoxy polyethylene glycol as an adjuvant improved protective immunity associated with a DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus in mice. Clin Vaccine Immunol (2014) 0.78
Oral immunization of mice with gamma-irradiated Brucella neotomae induces protection against intraperitoneal and intranasal challenge with virulent B. abortus 2308. PLoS One (2014) 0.78
Immune Response of Calves Vaccinated with Brucella abortus S19 or RB51 and Revaccinated with RB51. PLoS One (2015) 0.77
CD8 knockout mice are protected from challenge by vaccination with WR201, a live attenuated mutant of Brucella melitensis. Clin Dev Immunol (2013) 0.77
Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes. Gene (1995) 18.98
pBBR1MCS: a broad-host-range cloning vector. Biotechniques (1994) 8.71
Superficial antigens of Campylobacter (Vibrio) fetus: characterization of antiphagocytic component. Infect Immun (1975) 4.39
Outer membrane proteins of Brucella abortus: isolation and characterization. Infect Immun (1982) 3.07
Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther (2000) 2.95
Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice. Infect Immun (1986) 2.83
An antigenic analysis of Vibrio fetus. 3. Chemical, biologic, and antigenic properties of the endotoxin. Am J Vet Res (1966) 2.46
Protection against Brucella abortus in mice with O-polysaccharide-specific monoclonal antibodies. Infect Immun (1986) 2.32
The serum and secretory immunoglobulins of cattle: characterization and quantitation. J Immunol (1972) 2.22
Porins of Brucella species. Infect Immun (1984) 2.17
Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis. Infect Immun (1994) 1.93
Outer membrane proteins from rough strains of four Brucella species. Infect Immun (1984) 1.89
Survival of virulent and attenuated strains of Brucella abortus in normal and gamma interferon-activated murine peritoneal macrophages. Infect Immun (1992) 1.86
Microcapsule of Campylobacter fetus: chemical and physical characterization. Infect Immun (1978) 1.81
Macrophages and Brucella. Immunol Ser (1994) 1.77
Effectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against Brucella abortus in mice. Infect Immun (1988) 1.71
Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum. Infect Immun (1990) 1.56
Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4. Am J Vet Res (1996) 1.55
Persistent genital tract infection with Vibrio fetus intestinalis associated with serotypic alteration of the infecting strain. Am J Vet Res (1973) 1.51
Bovine veneral vibriosis: antigenic variation of the bacterium during infection. Infect Immun (1975) 1.46
Killing of Brucella abortus by bovine serum. Infect Immun (1988) 1.41
Comparative histopathology in BALB/c mice infected with virulent and attenuated strains of Brucella abortus. Vet Immunol Immunopathol (1990) 1.41
Immunoglobulin classes and biological functions of Campylobacter (Vibrio) fetus antibodies in serum and cervicovaginal mucus. Infect Immun (1974) 1.41
Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells. J Virol (2000) 1.40
Comparison of sodium dodecyl sulfate-polyacrylamide gel electrophoresis profiles and antigenic relatedness among outer membrane proteins of 49 Brucella abortus strains. Infect Immun (1984) 1.40
Characterization of the antibody for Vibrio fetus endotoxin in sera of normal and V. fetus infected cattle. J Immunol (1965) 1.36
Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines. Infect Immun (1994) 1.35
Flagellar ultrastructure and flagella-associated antigens of Campylobacter fetus. J Bacteriol (1975) 1.34
Comparative analyses of proteins extracted by hot saline or released spontaneously into outer membrane blebs from field strains of Brucella ovis and Brucella melitensis. Infect Immun (1989) 1.32
Bovine venereal vibriosis: variations in immunoglobulin class of antibodies in genital secretions and serum. Infect Immun (1974) 1.28
Immune response to porin in cattle immunized with whole cell, outer membrane, and outer membrane protein antigens of Brucella abortus combined with trehalose dimycolate and muramyl dipeptide adjuvants. Infect Immun (1983) 1.26
The siderophore 2,3-dihydroxybenzoic acid is not required for virulence of Brucella abortus in BALB/c mice. Infect Immun (1999) 1.24
Bovine veneral vibriosis: cure of genital infection in females by systemic immunization. Infect Immun (1975) 1.24
Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19. Immunology (1994) 1.23
Effects of penicillin and glycine on cell wall glycopeptides of the two varieties of Vibrio fetus. J Bacteriol (1968) 1.20
Coronavirus and Pasteurella infections in bovine shipping fever pneumonia and Evans' criteria for causation. J Clin Microbiol (2000) 1.14
Ethnicity and STIs: more than black and white. Sex Transm Infect (2001) 1.13
In vitro cytocidal effect of novel lytic peptides on Plasmodium falciparum and Trypanosoma cruzi. FASEB J (1988) 1.12
Pathogenicity and protective activity in pregnant goats of a Brucella melitensis Deltaomp25 deletion mutant. Res Vet Sci (2002) 1.08
Multiple regions of Harvey sarcoma virus RNA can dimerize in vitro. J Virol (1995) 1.07
Pathogenesis of abortion of bovine brucellosis. Comp Immunol Microbiol Infect Dis (1993) 1.07
Attenuation of a Brucella abortus mutant lacking a major 25 kDa outer membrane protein in cattle. Am J Vet Res (2001) 1.06
Bovine vibriosis: the distribution and specificity of antibodies induced by vaccination and infection and the immunofluorescent localization of the organism in infected heifers. Can J Comp Med (1971) 1.06
The origin, class and specificity of immunoglobulins in bovine cervico-vaginal mucus: variation with parenteral immunization and local infection with Vibrio fetus. J Reprod Fertil (1972) 1.03
Elimination of genital vibriosis in female cattle by systemic immunization with killed cells or cell-free extracts of Campylobacter fetus. J Infect Dis (1978) 1.02
Uptake of HIV testing in a genitourinary medicine clinic is affected by individual doctors. Sex Transm Infect (2001) 1.01
Murein (peptidoglycan) structure of Vibrio fetus. Comparison of a venereal and an intestinal strain. Biochim Biophys Acta (1971) 1.01
Immune response of cattle to Brucella abortus outer membrane proteins measured by lymphocyte blastogenesis. Vet Immunol Immunopathol (1985) 1.01
Brugia pahangi: effects of duration of infection and parasite burden on lymphatic lesion severity, granulomatous hypersensitivity, and immune responses in jirds (Meriones unguiculatus). Exp Parasitol (1990) 1.00
Brucella vaccines in wildlife. Vet Microbiol (2002) 1.00
A Brucella melitensis high temperature requirement A (htrA) deletion mutant demonstrates a stress response defective phenotype in vitro and transient attenuation in the BALB/c mouse model. Microb Pathog (1995) 1.00
In vitro cytocidal effect of lytic peptides on several transformed mammalian cell lines. Pept Res (1992) 1.00
Bovine vibriosis: the nature of the carrier state in the bull. J Infect Dis (1966) 0.96
The granulomatous inflammatory response in jirds, Meriones unguiculatus, to Brugia pahangi: an ultrastructural and histochemical comparison of the reaction in the lymphatics and peritoneal cavity. J Parasitol (1987) 0.95
Effect of the antimicrobial peptide, D-hecate, on trichomonads. J Parasitol (2000) 0.95
BALB/c mice infected with Brucella abortus express protracted polyclonal responses of both IgG2a and IgG3 isotypes. Immunol Lett (1994) 0.95
Phagocytosis, killing, and oxidant production by bovine monocyte-derived macrophages upon exposure to Brucella abortus strain 2308. Vet Immunol Immunopathol (1993) 0.94
Immune response in the bovine mammary gland after intestinal, local, and systemic immunization. Infect Immun (1981) 0.94
Risk factors for Brucella seropositivity in goat herds in eastern and western Uganda. Prev Vet Med (2001) 0.94
A multiplex approach to molecular detection of Brucella abortus and/or Mycobacterium bovis infection in cattle. J Clin Microbiol (2000) 0.94
Bovine venereal vibriosis: activity of inflammatory cells in protective immunity. Am J Vet Res (1975) 0.94
Comparative immune responses to native cell envelope antigens and the hot sodium dodecyl sulfate insoluble fraction (PG) of Brucella abortus in cattle and mice. Vet Immunol Immunopathol (1988) 0.94
Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams. Vet Immunol Immunopathol (1993) 0.93
Cloning and nucleotide sequence analysis of a Brucella abortus gene encoding an 18 kDa immunoreactive protein. Microb Pathog (1997) 0.92
Herpesvirus saimiri-induced malignant lymphoma in rabbits. J Natl Cancer Inst (1976) 0.92
Experimental infection of goat fetuses in utero with a stable, rough mutant of Brucella abortus. Res Vet Sci (1991) 0.92
Specific hypo-responsive granulomatous tissue reactions in Brugia pahangi-infected jirds. Acta Trop (1981) 0.92
Major histocompatibility complex class I and II expression on macrophages containing a virulent strain of Brucella abortus measured using green fluorescent protein-expressing brucellae and flow cytometry. FEMS Immunol Med Microbiol (2002) 0.92
Expression of the antimicrobial peptides in plants to control phytopathogenic bacteria and fungi. Plant Cell Rep (2006) 0.92
The morphological effects of two antimicrobial peptides, hecate-1 and melittin, on Escherichia coli. Scanning Microsc (1995) 0.91
Boundaries of telomere conversion in Trypanosoma brucei. Gene (1988) 0.90
A Brucella melitensis high-temperature-requirement A (htrA) deletion mutant is attenuated in goats and protects against abortion. Res Vet Sci (1998) 0.90
Effects of gamma radiation and azathioprine on Brucella abortus infection in BALB/c mice. Am J Vet Res (1991) 0.89
Evaluation of a transport medium for campylobacter (Vibrio) fetus. J Am Vet Med Assoc (1978) 0.88
Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51. Am J Vet Res (1998) 0.88
Immunity in the female bovine reproductive tract based on the response to "Campylobacter fetus". Adv Exp Med Biol (1981) 0.87
Focal necrotizing pneumonia in cats associated with a gram negative eugonic fermenting bacterium. Cornell Vet (1973) 0.87
In vitro and in vivo phenotypes resulting from deletion of the high temperature requirement A (htrA) gene from the bovine vaccine strain Brucella abortus S19. Vet Microbiol (1996) 0.87
Evaluation of a rough mutant of Brucella melitensis in pregnant goats. Res Vet Sci (1998) 0.87
Characterization of the caprine model for ruminant brucellosis. Vet Microbiol (2002) 0.87
Effects of presensitization on the development of lymphatic lesions in Brugia pahangi-infected jirds. Am J Trop Med Hyg (1982) 0.86
Morphologic lesions in Brucella abortus infected ovine fetuses. Vet Pathol (1986) 0.86
Diagnosis, treatment, and control of vibriosis in an artificial insemination center. J Am Vet Med Assoc (1968) 0.86
Reactions mediated by yeast mitochondrial group I and II introns. Cold Spring Harb Symp Quant Biol (1987) 0.85
Herpesvirus saimiri-induced lymphoproliferative disease in howler monkeys. J Natl Cancer Inst (1977) 0.85
Turnover products of the apo very low density lipoprotein II messenger RNA from chicken liver. Nucleic Acids Res (1988) 0.85
Interleukin 2 promoter/enhancer controlled expression of a synthetic cecropin-class lytic peptide in transgenic mice and subsequent resistance to Brucella abortus. Transgenic Res (1997) 0.85
Discrimination between RNA circles, interlocked RNA circles and lariats using two-dimensional polyacrylamide gel electrophoresis. Nucleic Acids Res (1988) 0.85
Natural and immune antibodies for Vibrio fetus in serum and secretions of cattle. Infect Immun (1972) 0.85